http://articles.mercola.com/sites/articles/archive/2001/10/20/drug-companies-part-four.aspxGeneric-drug makers are appealing to Congress to stop Bristol-Myers Squibb Co. in what they say would be a precedent-setting move to protect a key drug from cheaper rivals. The New York-based drug maker is using legal maneuvers to try to keep genericenCommunityServer 2008.5 SP1 (Build: 31106.3070)